Literature DB >> 11971957

Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259.

Amardeep S Dhillon1, Claire Pollock, Helge Steen, Peter E Shaw, Harald Mischak, Walter Kolch.   

Abstract

The Raf-1 kinase activates the ERK (extracellular-signal-regulated kinase) pathway. The cyclic AMP (cAMP)-dependent protein kinase (PKA) can inhibit Raf-1 by direct phosphorylation. We have mapped all cAMP-induced phosphorylation sites in Raf-1, showing that serines 43, 259, and 621 are phosphorylated by PKA in vitro and induced by cAMP in vivo. Serine 43 phosphorylation decreased the binding to Ras in serum-starved but not in mitogen-stimulated cells. However, the kinase activity of a RafS43A mutant was fully inhibited by PKA. Mutation of serine 259 increased the basal Raf-1 activity and rendered it largely resistant to inhibition by PKA. cAMP increased Raf-1 serine 259 phosphorylation in a PKA-dependent manner with kinetics that correlated with ERK deactivation. PKA also decreased Raf-1 serine 338 phosphorylation of Raf-1, previously shown to be required for Raf-1 activation. Serine 338 phosphorylation of a RafS259A mutant was unaffected by PKA. Using RafS259 mutants we also demonstrate that Raf-1 is the sole target for PKA inhibition of ERK and ERK-induced gene expression, and that Raf-1 inhibition is mediated mainly through serine 259 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11971957      PMCID: PMC133783          DOI: 10.1128/MCB.22.10.3237-3246.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt.

Authors:  C Rommel; B A Clarke; S Zimmermann; L Nuñez; R Rossman; K Reid; K Moelling; G D Yancopoulos; D J Glass
Journal:  Science       Date:  1999-11-26       Impact factor: 47.728

Review 2.  14-3-3 proteins: structure, function, and regulation.

Authors:  H Fu; R R Subramanian; S C Masters
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

Review 3.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

Review 4.  Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling.

Authors:  M D Houslay; W Kolch
Journal:  Mol Pharmacol       Date:  2000-10       Impact factor: 4.436

5.  Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association.

Authors:  M T Yip-Schneider; W Miao; A Lin; D S Barnard; G Tzivion; M S Marshall
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

6.  cAMP-dependent protein kinase (PKA) inhibits T cell activation by phosphorylating ser-43 of raf-1 in the MAPK/ERK pathway.

Authors:  C Ramstad; V Sundvold; H K Johansen; T Lea
Journal:  Cell Signal       Date:  2000-08       Impact factor: 4.315

Review 7.  The complexity of Raf-1 regulation.

Authors:  D K Morrison; R E Cutler
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

8.  Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation.

Authors:  D Abraham; K Podar; M Pacher; M Kubicek; N Welzel; B A Hemmings; S M Dilworth; H Mischak; W Kolch; M Baccarini
Journal:  J Biol Chem       Date:  2000-07-21       Impact factor: 5.157

9.  Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase.

Authors:  A K Howe; R L Juliano
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

10.  Phosphorylation of serine 43 is not required for inhibition of c-Raf kinase by the cAMP-dependent protein kinase.

Authors:  M F Sidovar; P Kozlowski; J W Lee; M A Collins; Y He; L M Graves
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

View more
  69 in total

1.  Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins.

Authors:  Najma Begum; Steven Hockman; Vincent C Manganiello
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

Review 2.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

3.  Differential effects of vitamin K1 on AFP and DCP levels in patients with unresectable HCC and in HCC cell lines.

Authors:  Brian I Carr; Ziqiu Wang; Meifung Wang; Gang Wei
Journal:  Dig Dis Sci       Date:  2010-12-28       Impact factor: 3.199

4.  Ras binding opens c-Raf to expose the docking site for mitogen-activated protein kinase kinase.

Authors:  Kenta Terai; Michiyuki Matsuda
Journal:  EMBO Rep       Date:  2005-03       Impact factor: 8.807

Review 5.  Tumor adaptation and resistance to RAF inhibitors.

Authors:  Piro Lito; Neal Rosen; David B Solit
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 6.  Vitamin D and differentiation in cancer.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

7.  Mitogen-activated protein kinase (MAPK) hyperactivation and enhanced NRAS expression drive acquired vemurafenib resistance in V600E BRAF melanoma cells.

Authors:  Michael Lidsky; Gamil Antoun; Paul Speicher; Bartley Adams; Ryan Turley; Christi Augustine; Douglas Tyler; Francis Ali-Osman
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

8.  Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.

Authors:  Tilman Brummer; Mark Larance; Maria Teresa Herrera Abreu; Ruth J Lyons; Paul Timpson; Christoph H Emmerich; Emmy D G Fleuren; Gillian M Lehrbach; Daniel Schramek; Michael Guilhaus; David E James; Roger J Daly
Journal:  EMBO J       Date:  2008-09-03       Impact factor: 11.598

9.  Differential regulation of B-raf isoforms by phosphorylation and autoinhibitory mechanisms.

Authors:  Isabelle Hmitou; Sabine Druillennec; Agathe Valluet; Carole Peyssonnaux; Alain Eychène
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

10.  Akt and ERK1/2 pathways are components of the vasopressin signaling network in rat native IMCD.

Authors:  Trairak Pisitkun; Vinitha Jacob; Stephen M Schleicher; Chung-Lin Chou; Ming-Jiun Yu; Mark A Knepper
Journal:  Am J Physiol Renal Physiol       Date:  2008-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.